BioCina and CelluTx Partner for Next-Gen mcDNA Production
BioCina Pty Ltd. has announced an exclusive agreement to utilise CelluTx’s recombination-based plasmid system (RBPS) technology with its CDMO clients. The RBPS technology is a novel…
BioCina Pty Ltd. has announced an exclusive agreement to utilise CelluTx’s recombination-based plasmid system (RBPS) technology with its CDMO clients. The RBPS technology is a novel…
BioCina Pty Ltd., a global biologics Contract Development and Manufacturing Organization (CDMO), has announced the acquisition of exclusive rights to utilize CelluTx’s Recombination Based Plasmid…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.